DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Plaque assay / TCID50/ qRT-PCR are 23

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_7558	Chlorpromazine	Antiinflammatory and antineoplastic	Schizophrenia	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52286	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7579	Amodiaquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52281	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7580	Amodiaquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52281	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved	32438446
DrugRepV_7583	Amodiaquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52282	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7586	Fluspirilene	Nervous System	Schizophrenia	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52289	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved, Investigational	32438446
DrugRepV_7587	Fluspirilene	Nervous System	Schizophrenia	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52289	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved, Investigational	32438446
DrugRepV_7590	Clomipramine	Nervous System	Depression, schizophrenia, Tourette disorder	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52287	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7593	Baricitinib	Antineoplastic and Immunomodulating Agents	Rheumatoid arthritis	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52283	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved, Investigational	32438446
DrugRepV_7594	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52291	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7595	Imatinib	Antineoplastic and Immunomodulating Agents	Leukemia | Myelodysplastic/myeloproliferative disease | Gastrointestinal stromal tumors	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52291	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved	32438446
DrugRepV_7596	Mefloquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52281	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved, Investigational	32438446
DrugRepV_7597	Mefloquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52281	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved, Investigational	32438446
DrugRepV_7598	Promethazine	Dermatologicals	Rhinitis, allergic conjunctivitis, allergic reactions, anaphylactic reactions, sedation, nausea, vomiting, pain, motion sickness.	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52292	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved, Investigational	32438446
DrugRepV_7599	Promethazine	Dermatologicals	Rhinitis, allergic conjunctivitis, allergic reactions, anaphylactic reactions, sedation, nausea, vomiting, pain, motion sickness.	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52292	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved, Investigational	32438446
DrugRepV_7614	Fluphenazine	Nervous System	Psychosis	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52288	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7615	Hydroxychloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52290	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7616	Hydroxychloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52290	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved	32438446
DrugRepV_7618	Tamoxifen	Antineoplastic and Immunomodulating Agents	Breast cancer	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52293	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7619	Tamoxifen	Antineoplastic and Immunomodulating Agents	Breast cancer	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52293	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved	32438446
DrugRepV_7624	Benztropine	Nervous System	Parkinson disease	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52284	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446
DrugRepV_7637	Toremifene	Antineoplastic and Immunomodulating Agents	Breast Cancer	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52294	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved, Investigational	32438446
DrugRepV_7638	Toremifene	Antineoplastic and Immunomodulating Agents	Breast Cancer	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52294	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (90 %)	Approved, Investigational	32438446
DrugRepV_7654	Chloroquine	Antiparasitic products, Insectisides and Repellents	Malaria	SARS Coronavirus-2	WA-1 strain - BEI ; NR-52285	NA	Plaque assay / TCID50/ qRT-PCR	Decrease (50 %)	Approved	32438446